Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Smallpox vaccine (NYCBH vaccinia strain) - sanofi pasteur/NIAID

Drug Profile

Smallpox vaccine (NYCBH vaccinia strain) - sanofi pasteur/NIAID

Alternative Names: Aventis Pasteur smallpox vaccine (APSV); NYCBH vaccinia strain smallpox vaccine - Aventis Pasteur; Vaccinia virus vaccine - NIAID/Aventis Pasteur; Wetvax

Latest Information Update: 16 Mar 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi pasteur
  • Developer National Institute of Allergy and Infectious Diseases; sanofi pasteur
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Smallpox

Most Recent Events

  • 21 Jan 2005 Aventis Pasteur is now called sanofi pasteur.
  • 13 Oct 2004 A clinical study has been added to the adverse events and Viral Infections immunogenicity sections ,
  • 03 Jul 2003 A case report has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top